The MarketWatch News Department was not involved in the creation of this content.
Sep 27, 2020 (CDN Newswire via Comtex) —
The report titled Global Needle-Free Injection Device Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 introduced by MarketQuest.biz offers a whole study of the parent market, synopsis, new industry data, and innovative future tendencies, ruling vendors, and predictions, analysis. The report highlights various market dynamics like trends, drivers, challenges, and opportunities. The report discusses the market dimensions, analysis of market share, and outline of the competitive scene and top merchants in the industry. The report is segregated by company, by country, and by application/types for the competitive landscape analysis. The research further includes the introduction of firms in the global Needle-Free Injection Device market along with their summary, earnings division, study findings, and completion.
Key players covered in the report: Zogenix, Antares Pharma, Akra Dermojet, Inovio,
Manufactured on GF’s 22FDX platform, Movano’s radio frequency-enabled solution will help individuals to manage their glucose levels anywhere, anytime
GlobalFoundries Global Technology Conference
Pleasanton and Santa Clara, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) — Movano Inc., a health-focused technology company developing non-invasive solutions to enhance the quality of life for people affected by chronic health conditions, today announced a strategic collaboration with GLOBALFOUNDRIES® (GF®) to advance the commercialization of Movano’s wearable, non-invasive continuous glucose monitor (CGM), which is currently in development. The announcement was made at GF’s annual Global Technology Conference (GTC).
Movano’s novel approach to glucose monitoring is based on its patent-pending radio frequency (RF) sensor platform, which is built on GF’s 22FDX® (22nm FD-SOI) solution, to enable the creation of high performance and small form-factor sensors that are low-power and cost-effectively manufactured at scale.
“The last few months have spurred a growing need for